Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
The global market for Heparin (Heparin Sodium and Heparin Calcium) was estimated to be worth US$ 2632.1 million in 2023 and is forecast to a readjusted size of US$ 6113.5 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.
In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.
Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.
The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.

Global Leading Market Research Publisher QYResearch announces the release of its latest report “Heparin (Heparin Sodium and Heparin Calcium) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Heparin (Heparin Sodium and Heparin Calcium) market, including market size, share, demand, industry development status, and forecasts for the next few years.

The report provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.

This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/2337244/heparin--heparin-sodium-and-heparin-calcium

Global Heparin (Heparin Sodium and Heparin Calcium) Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2019 to 2030, as well as the production volume by region during the same period.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Heparin (Heparin Sodium and Heparin Calcium) market is segmented as below:

By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical

Segment by Type
Heparin Sodium
Heparin Calcium

Segment by Application
UFH
LMWH

Each chapter of the report provides detailed information for readers to further understand the Heparin (Heparin Sodium and Heparin Calcium) market:
Chapter 1: Heparin (Heparin Sodium and Heparin Calcium) Market Product Definition, Product Types, Sales Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Household Hazardous Waste Disposal, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Heparin (Heparin Sodium and Heparin Calcium) industry.
Chapter 3: Heparin (Heparin Sodium and Heparin Calcium) Market Historical (2019-2023) and forecast (2024-2030) sales and revenue analysis of Heparin (Heparin Sodium and Heparin Calcium) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Heparin (Heparin Sodium and Heparin Calcium) Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2019 to 2024.
Chapter 5 to 9: Heparin (Heparin Sodium and Heparin Calcium) Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Heparin (Heparin Sodium and Heparin Calcium) introduction, etc. Heparin (Heparin Sodium and Heparin Calcium) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, including raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Heparin (Heparin Sodium and Heparin Calcium) market based on comprehensive survey.
Chapter 14: Methodology and Data Sources.

Table of Contents
1 Heparin (Heparin Sodium and Heparin Calcium) Market Overview
1.1Heparin (Heparin Sodium and Heparin Calcium) Product Overview
1.2 Heparin (Heparin Sodium and Heparin Calcium) Market by Type
1.3 Global Heparin (Heparin Sodium and Heparin Calcium) Market Size by Type
1.3.1 Global Heparin (Heparin Sodium and Heparin Calcium) Market Size Overview by Type (2019-2030)
1.3.2 Global Heparin (Heparin Sodium and Heparin Calcium) Historic Market Size Review by Type (2019-2024)
1.3.3 Global Heparin (Heparin Sodium and Heparin Calcium) Forecasted Market Size by Type (2025-2030)
1.4 Key Regions Market Size by Type
1.4.1 North America Heparin (Heparin Sodium and Heparin Calcium) Sales Breakdown by Type (2019-2024)
1.4.2 Europe Heparin (Heparin Sodium and Heparin Calcium) Sales Breakdown by Type (2019-2024)
1.4.3 Asia-Pacific Heparin (Heparin Sodium and Heparin Calcium) Sales Breakdown by Type (2019-2024)
1.4.4 Latin America Heparin (Heparin Sodium and Heparin Calcium) Sales Breakdown by Type (2019-2024)
1.4.5 Middle East and Africa Heparin (Heparin Sodium and Heparin Calcium) Sales Breakdown by Type (2019-2024)
2 Heparin (Heparin Sodium and Heparin Calcium) Market Competition by Company
2.1 Global Top Players by Heparin (Heparin Sodium and Heparin Calcium) Sales (2019-2024)
2.2 Global Top Players by Heparin (Heparin Sodium and Heparin Calcium) Revenue (2019-2024)
2.3 Global Top Players by Heparin (Heparin Sodium and Heparin Calcium) Price (2019-2024)
2.4 Global Top Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Heparin (Heparin Sodium and Heparin Calcium) Market Competitive Situation and Trends
2.5.1 Heparin (Heparin Sodium and Heparin Calcium) Market Concentration Rate (2019-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Heparin (Heparin Sodium and Heparin Calcium) Sales and Revenue in 2023
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin (Heparin Sodium and Heparin Calcium) as of 2023)
2.7 Date of Key Manufacturers Enter into Heparin (Heparin Sodium and Heparin Calcium) Market
2.8 Key Manufacturers Heparin (Heparin Sodium and Heparin Calcium) Product Offered
2.9 Mergers & Acquisitions, Expansion
...

Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.

To contact us and get this report: https://www.qyresearch.com/contact-us

About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp

お気に入りの記事を「いいね！」で応援しよう